{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T19:41:31Z","timestamp":1790710891130,"version":"4.1.0"},"reference-count":82,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,6,10]],"date-time":"2022-06-10T00:00:00Z","timestamp":1654819200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,6,10]],"date-time":"2022-06-10T00:00:00Z","timestamp":1654819200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000615","name":"Fight for Sight UK","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000615","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Glaucoma UK"},{"DOI":"10.13039\/501100009187","name":"Mason Medical Research Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100009187","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100011598","name":"UK and Eire Glaucoma Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011598","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Glaucoma is a complex neurodegenerative disease resulting in progressive optic neuropathy and is a leading cause of irreversible blindness worldwide. Primary open angle glaucoma (POAG) is the predominant form affecting 65.5 million people globally. Despite the prevalence of POAG and the identification of over 120 glaucoma related genetic loci, the underlaying molecular mechanisms are still poorly understood. The transforming growth factor beta (TGF-\u03b2) signalling pathway is implicated in the molecular pathology of POAG. To gain a better understanding of the role TGF-\u03b22 plays in the glaucomatous changes to the molecular pathology in the trabecular meshwork, we employed RNA-Seq to delineate the TGF-\u03b22 induced changes in the transcriptome of normal primary human trabecular meshwork cells (HTM). We identified a significant number of differentially expressed genes and associated pathways that contribute to the pathogenesis of POAG. The differentially expressed genes were predominantly enriched in ECM regulation, TGF-\u03b2 signalling, proliferation\/apoptosis, inflammation\/wound healing, MAPK signalling, oxidative stress and RHO signalling. Canonical pathway analysis confirmed the enrichment of RhoA signalling, inflammatory-related processes, ECM and cytoskeletal organisation in HTM cells in response to TGF-\u03b22. We also identified novel genes and pathways that were affected after TGF-\u03b22 treatment in the HTM, suggesting additional pathways are activated, including Nrf2, PI3K-Akt, MAPK and HIPPO signalling pathways. The identification and characterisation of TGF-\u03b22 dependent differentially expressed genes and pathways in HTM cells is essential to understand the patho-physiology of glaucoma and to develop new therapeutic agents.<\/jats:p>","DOI":"10.1038\/s41598-022-13573-8","type":"journal-article","created":{"date-parts":[[2022,6,10]],"date-time":"2022-06-10T06:05:00Z","timestamp":1654841100000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":33,"title":["Genome-wide transcriptome profiling of human trabecular meshwork cells treated with TGF-\u03b22"],"prefix":"10.1038","volume":"12","author":[{"given":"Breedge","family":"Callaghan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Lester","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Lane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaochen","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katarzyna","family":"Goljanek-Whysall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Simpson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carl","family":"Sheridan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colin E.","family":"Willoughby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,6,10]]},"reference":[{"issue":"10108","key":"13573_CR1","doi-asserted-by":"publisher","first-page":"2183","DOI":"10.1016\/S0140-6736(17)31469-1","volume":"390","author":"JB Jonas","year":"2017","unstructured":"Jonas, J. B. et al. Glaucoma. The Lancet 390(10108), 2183\u20132193 (2017).","journal-title":"The Lancet"},{"issue":"2","key":"13573_CR2","doi-asserted-by":"publisher","first-page":"e130","DOI":"10.1016\/S2214-109X(20)30425-3","volume":"9","author":"R Bourne","year":"2021","unstructured":"Bourne, R. et al. Trends in prevalence of blindness and distance and near vision impairment over 30 years: An analysis for the Global Burden of Disease Study. Lancet Glob. Health 9(2), e130\u2013e143 (2021).","journal-title":"Lancet Glob. Health"},{"key":"13573_CR3","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.exer.2018.11.005","volume":"183","author":"S Alqawlaq","year":"2019","unstructured":"Alqawlaq, S., Flanagan, J. G. & Sivak, J. M. All roads lead to glaucoma: Induced retinal injury cascades contribute to a common neurodegenerative outcome. Exp. Eye Res. 183, 88\u201397 (2019).","journal-title":"Exp. Eye Res."},{"issue":"8","key":"13573_CR4","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1001\/archopht.1991.01080080050026","volume":"109","author":"A Sommer","year":"1991","unstructured":"Sommer, A. et al. Relationship Between Intraocular Pressure and Primary Open Angle Glaucoma Among White and Black Americans: The Baltimore Eye Survey. Arch. Ophthalmol. 109(8), 1090\u20131095 (1991).","journal-title":"Arch. Ophthalmol."},{"issue":"1","key":"13573_CR5","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1038\/s41433-019-0687-5","volume":"34","author":"R Wormald","year":"2020","unstructured":"Wormald, R., Virgili, G. & Azuara-Blanco, A. Systematic reviews and randomised controlled trials on open angle glaucoma. Eye 34(1), 161\u2013167 (2020).","journal-title":"Eye"},{"key":"13573_CR6","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.ejpb.2015.04.029","volume":"95","author":"BM Braunger","year":"2015","unstructured":"Braunger, B. M., Fuchshofer, R. & Tamm, E. R. The aqueous humor outflow pathways in glaucoma: A unifying concept of disease mechanisms and causative treatment. Eur. J. Pharm. Biopharm. 95, 173\u2013181 (2015).","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"1","key":"13573_CR7","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1038\/s41467-020-20851-4","volume":"12","author":"P Gharahkhani","year":"2021","unstructured":"Gharahkhani, P. et al. Genome-wide meta-analysis identifies 127 open-angle glaucoma loci with consistent effect across ancestries. Nat. Commun. 12(1), 1258 (2021).","journal-title":"Nat. Commun."},{"key":"13573_CR8","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.preteyeres.2017.02.001","volume":"58","author":"ID Danford","year":"2017","unstructured":"Danford, I. D. et al. Characterizing the \u201cPOAGome\u201d: A bioinformatics-driven approach to primary open-angle glaucoma. Prog. Retina. Eye Res. 58, 89\u2013114 (2017).","journal-title":"Prog. Retina. Eye Res."},{"issue":"6","key":"13573_CR9","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1136\/bjophthalmol-2011-301132","volume":"97","author":"MA Prendes","year":"2013","unstructured":"Prendes, M. A., Harris, A., Wirostko, B. M., Gerber, A. L. & Siesky, B. The role of transforming growth factor \u03b2 in glaucoma and the therapeutic implications. Br. J. Ophthalmol. 97(6), 680\u2013686 (2013).","journal-title":"Br. J. Ophthalmol."},{"issue":"2","key":"13573_CR10","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1007\/s004170000241","volume":"239","author":"M Inatani","year":"2001","unstructured":"Inatani, M. et al. Transforming growth factor-beta 2 levels in aqueous humor of glaucomatous eyes. Graefe\u2019s Arch. Clin. Exp. Ophthalmol. 239(2), 109\u2013113 (2001).","journal-title":"Graefe\u2019s Arch. Clin. Exp. Ophthalmol."},{"issue":"6","key":"13573_CR11","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1006\/exer.1994.1158","volume":"59","author":"RC Tripathi","year":"1994","unstructured":"Tripathi, R. C., Li, J., Chan, W. F. & Tripathi, B. J. Aqueous humor in glaucomatous eyes contains an increased level of TGF-beta 2. Exp. Eye Res. 59(6), 723\u2013727 (1994).","journal-title":"Exp. Eye Res."},{"issue":"2\u20133","key":"13573_CR12","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1089\/jop.2013.0220","volume":"30","author":"RJ Wordinger","year":"2014","unstructured":"Wordinger, R. J., Sharma, T. & Clark, A. F. The role of TGF-\u03b22 and bone morphogenetic proteins in the trabecular meshwork and glaucoma. J. Ocular Pharmacol. Ther. 30(2\u20133), 154\u2013162 (2014).","journal-title":"J. Ocular Pharmacol. Ther."},{"issue":"10","key":"13573_CR13","doi-asserted-by":"publisher","first-page":"963","DOI":"10.3109\/02713689009069932","volume":"9","author":"HD Jampel","year":"1990","unstructured":"Jampel, H. D., Roche, N., Stark, W. J. & Roberts, A. B. Transforming growth factor-\u03b2 in human aqueous humor. Curr. Eye Res. 9(10), 963\u2013969 (1990).","journal-title":"Curr. Eye Res."},{"issue":"4","key":"13573_CR14","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1016\/j.exer.2011.06.011","volume":"93","author":"T Tovar-Vidales","year":"2011","unstructured":"Tovar-Vidales, T., Clark, A. F. & Wordinger, R. J. Transforming growth factor-beta2 utilizes the canonical Smad-signaling pathway to regulate tissue transglutaminase expression in human trabecular meshwork cells. Exp. Eye Res. 93(4), 442\u2013451 (2011).","journal-title":"Exp. Eye Res."},{"issue":"4","key":"13573_CR15","doi-asserted-by":"publisher","first-page":"2067","DOI":"10.1167\/iovs.09-4567","volume":"51","author":"AR Shepard","year":"2010","unstructured":"Shepard, A. R. et al. Adenoviral gene transfer of active human transforming growth factor-\u03b22 elevates intraocular pressure and reduces outflow facility in rodent eyes. Invest. Ophthalmol. Vis. Sci. 51(4), 2067\u20132076 (2010).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"1","key":"13573_CR16","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1167\/iovs.05-1060","volume":"47","author":"DL Fleenor","year":"2006","unstructured":"Fleenor, D. L. et al. TGF\u03b22-induced changes in human trabecular meshwork: Implications for intraocular pressure. Invest. Ophthalmol. Vis. Sci. 47(1), 226\u2013234 (2006).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"6","key":"13573_CR17","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1006\/exer.1993.1085","volume":"56","author":"JW Rohen","year":"1993","unstructured":"Rohen, J. W., L\u00fctjen-Drecoll, E., Fl\u00fcgel, C., Meyer, M. & Grierson, I. Ultrastructure of the trabecular meshwork in untreated cases of primary open-angle glaucoma (POAG). Exp. Eye Res. 56(6), 683\u2013692 (1993).","journal-title":"Exp. Eye Res."},{"issue":"2","key":"13573_CR18","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1097\/00061198-199704000-00009","volume":"6","author":"J Gottanka","year":"1997","unstructured":"Gottanka, J., Johnson, D. H., Martus, P. & L\u00fctjen-Drecoll, E. Severity of optic nerve damage in eyes with POAG is correlated with changes in the trabecular meshwork. J. Glaucoma 6(2), 123\u2013132\u00a0(1997).","journal-title":"J. Glaucoma"},{"issue":"1","key":"13573_CR19","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1007\/s00441-011-1274-7","volume":"347","author":"R Fuchshofer","year":"2012","unstructured":"Fuchshofer, R. & Tamm, E. R. The role of TGF-\u03b2 in the pathogenesis of primary open-angle glaucoma. Cell Tissue Res. 347(1), 279\u2013290 (2012).","journal-title":"Cell Tissue Res."},{"issue":"7","key":"13573_CR20","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1038\/s41580-018-0007-0","volume":"19","author":"CJ David","year":"2018","unstructured":"David, C. J. & Massagu\u00e9, J. Contextual determinants of TGF\u03b2 action in development, immunity and cancer. Nat. Rev. Mol. Cell Biol. 19(7), 419\u2013435 (2018).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"11","key":"13573_CR21","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1038\/nrc1208","volume":"3","author":"PM Siegel","year":"2003","unstructured":"Siegel, P. M. & Massagu\u00e9, J. Cytostatic and apoptotic actions of TGF-\u03b2 in homeostasis and cancer. Nat. Rev. Cancer 3(11), 807\u2013820 (2003).","journal-title":"Nat. Rev. Cancer"},{"issue":"4","key":"13573_CR22","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1097\/IJG.0000000000000627","volume":"26","author":"J Wang","year":"2017","unstructured":"Wang, J. et al. Targeting transforming growth factor-\u03b2 signaling in primary open-angle glaucoma. J. Glaucoma 26(4), 390\u2013395 (2017).","journal-title":"J. Glaucoma"},{"issue":"6","key":"13573_CR23","first-page":"1020","volume":"88","author":"R Fuchshofer","year":"2011","unstructured":"Fuchshofer, R., Stephan, D. A., Russell, P. & Tamm, E. R. Gene expression profiling of TGF\u03b22- and\/or BMP7-treated trabecular meshwork cells: Identification of Smad7 as a critical inhibitor of TGF-\u03b22 signaling. Gene Expr. 88(6), 1020\u20131032 (2011).","journal-title":"Gene Expr."},{"issue":"11","key":"13573_CR24","doi-asserted-by":"publisher","first-page":"4023","DOI":"10.1167\/iovs.04-0535","volume":"45","author":"X Zhao","year":"2004","unstructured":"Zhao, X., Ramsey, K. E., Stephan, D. A. & Russell, P. Gene and protein expression changes in human trabecular meshwork cells treated with transforming growth factor-beta. Invest. Ophthalmol. Vis. Sci. 45(11), 4023\u20134034 (2004).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"5","key":"13573_CR25","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/j.exer.2004.07.005","volume":"79","author":"C Fl\u00fcgel-Koch","year":"2004","unstructured":"Fl\u00fcgel-Koch, C., Ohlmann, A., Fuchshofer, R., Welge-L\u00fcssen, U. & Tamm, E. R. Thrombospondin-1 in the trabecular meshwork: Localization in normal and glaucomatous eyes, and induction by TGF-\u03b21 and dexamethasone in vitro. Exp. Eye Res. 79(5), 649\u2013663 (2004).","journal-title":"Exp. Eye Res."},{"issue":"10","key":"13573_CR26","doi-asserted-by":"publisher","first-page":"6779","DOI":"10.1167\/iovs.13-12298","volume":"54","author":"WE Medina-Ortiz","year":"2013","unstructured":"Medina-Ortiz, W. E., Belmares, R., Neubauer, S., Wordinger, R. J. & Clark, A. F. Cellular fibronectin expression in human trabecular meshwork and induction by transforming growth factor-\u03b22. Invest. Ophthalmol. Vis. Sci. 54(10), 6779\u20136788 (2013).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"1","key":"13573_CR27","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0078644","volume":"9","author":"S Zhao","year":"2014","unstructured":"Zhao, S., Fung-Leung, W.-P., Bittner, A., Ngo, K. & Liu, X. Comparison of RNA-Seq and microarray in transcriptome profiling of activated T cells. PLoS ONE 9(1), e78644 (2014).","journal-title":"PLoS ONE"},{"issue":"9","key":"13573_CR28","doi-asserted-by":"publisher","first-page":"6382","DOI":"10.1167\/iovs.13-12128","volume":"54","author":"Y Liu","year":"2013","unstructured":"Liu, Y. et al. Gene expression profile in human trabecular meshwork from patients with primary open-angle glaucoma. Invest. Ophthalmol. Vis. Sci. 54(9), 6382\u20136389 (2013).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"13573_CR29","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.exer.2018.03.001","volume":"171","author":"KE Keller","year":"2018","unstructured":"Keller, K. E. et al. Consensus recommendations for trabecular meshwork cell isolation, characterization and culture. Exp. Eye Res. 171, 164\u2013173 (2018).","journal-title":"Exp. Eye Res."},{"issue":"1","key":"13573_CR30","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/nprot.2008.211","volume":"4","author":"DW Huang","year":"2009","unstructured":"Huang, D. W., Sherman, B. T. & Lempicki, R. A. Systematic and integrative analysis of large gene lists using DAVID Bioinformatics Resources. Nat. Protoc. 4(1), 44\u201357 (2009).","journal-title":"Nat. Protoc."},{"issue":"1","key":"13573_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/nar\/gkn923","volume":"37","author":"DW Huang","year":"2009","unstructured":"Huang, D. W., Sherman, B. T. & Lempicki, R. A. Bioinformatics enrichment tools: Paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res. 37(1), 1\u201313 (2009).","journal-title":"Nucleic Acids Res."},{"issue":"11","key":"13573_CR32","doi-asserted-by":"publisher","first-page":"2498","DOI":"10.1101\/gr.1239303","volume":"13","author":"P Shannon","year":"2003","unstructured":"Shannon, P. et al. Cytoscape: A software environment for integrated models of biomolecular interaction network. Genome Res. 13(11), 2498\u20132504 (2003).","journal-title":"Genome Res."},{"issue":"7","key":"13573_CR33","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1038\/nrg2795","volume":"11","author":"RD Hawkins","year":"2010","unstructured":"Hawkins, R. D., Hon, G. C. & Ren, B. Next-generation genomics: An integrative approach. Nat. Rev. Genet. 11(7), 476\u2013486 (2010).","journal-title":"Nat. Rev. Genet."},{"issue":"1","key":"13573_CR34","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/nrg2484","volume":"10","author":"Z Wang","year":"2009","unstructured":"Wang, Z., Gerstein, M. & Snyder, M. RNA-Seq: A revolutionary tool for transcriptomics. Nat. Rev. Genet. 10(1), 57\u201363 (2009).","journal-title":"Nat. Rev. Genet."},{"issue":"11","key":"13573_CR35","doi-asserted-by":"publisher","first-page":"6747","DOI":"10.1167\/iovs.15-17720","volume":"56","author":"J Cai","year":"2015","unstructured":"Cai, J. et al. Expression profiling of human Schlemm\u2019s canal endothelial cells from eyes with and without glaucoma. Invest. Ophthalmol. Vis. Sci. 56(11), 6747\u20136753 (2015).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"10","key":"13573_CR36","first-page":"1285","volume":"29","author":"AI Iglesias","year":"2015","unstructured":"Iglesias, A. I. et al. Genes, pathways, and animal models in primary open-angle glaucoma. Eye (Basingstoke) 29(10), 1285\u20131298 (2015).","journal-title":"Eye (Basingstoke)"},{"issue":"2","key":"13573_CR37","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1038\/s41588-019-0556-y","volume":"52","author":"JE Craig","year":"2020","unstructured":"Craig, J. E. et al. Multitrait analysis of glaucoma identifies new risk loci and enables polygenic prediction of disease susceptibility and progression. Nat. Genet. 52(2), 160\u2013166 (2020).","journal-title":"Nat. Genet."},{"issue":"8","key":"13573_CR38","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1038\/s41576-019-0127-1","volume":"20","author":"V Tam","year":"2019","unstructured":"Tam, V. et al. Benefits and limitations of genome-wide association studies. Nat. Rev. Genet. 20(8), 467\u2013484 (2019).","journal-title":"Nat. Rev. Genet."},{"key":"13573_CR39","doi-asserted-by":"publisher","first-page":"R1","DOI":"10.1093\/hmg\/ddx184","volume":"26","author":"JL Wiggs","year":"2017","unstructured":"Wiggs, J. L. & Pasquale, L. R. Genetics of glaucoma. Hum. Mol. Genet. 26, R1\u2013R27 (2017).","journal-title":"Hum. Mol. Genet."},{"issue":"6","key":"13573_CR40","doi-asserted-by":"publisher","first-page":"2002","DOI":"10.1167\/iovs.04-1477","volume":"46","author":"RR Allingham","year":"2005","unstructured":"Allingham, R. R. et al. Early adult-onset POAG linked to 15q11\u201313 using ordered subset analysis. Investig. Ophthalmol. Vis. Sci. 46(6), 2002 (2005).","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"issue":"5","key":"13573_CR41","doi-asserted-by":"publisher","first-page":"1886","DOI":"10.1167\/iovs.07-0414","volume":"49","author":"BJ Fan","year":"2008","unstructured":"Fan, B. J., Wang, D. Y., Tham, C. C. Y., Lam, D. S. C. & Pang, C. P. Gene expression profiles of human trabecular meshwork cells induced by triamcinolone and dexamethasone. Invest. Ophthalmol. Vis. Sci. 49(5), 1886\u20131897 (2008).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"6494","key":"13573_CR42","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1038\/371257a0","volume":"371","author":"GJ Hannon","year":"1994","unstructured":"Hannon, G. J. & Beach, D. Pl5INK4B is a potentia| effector of TGF-\u03b2-induced cell cycle arrest. Nature 371(6494), 257\u2013261 (1994).","journal-title":"Nature"},{"issue":"2","key":"13573_CR43","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1161\/CIRCRESAHA.115.307906","volume":"118","author":"V Nanda","year":"2016","unstructured":"Nanda, V. et al. CDKN2B regulates TGF \u03b2 signaling and smooth muscle cell investment of hypoxic neovessels. Circ. Res. 118(2), 230\u2013240 (2016).","journal-title":"Circ. Res."},{"issue":"9","key":"13573_CR44","doi-asserted-by":"publisher","first-page":"1934","DOI":"10.3390\/cells9091934","volume":"9","author":"S Rathi","year":"2020","unstructured":"Rathi, S. et al. Molecular genetics and functional analysis implicate CDKN2BAS1-CDKN2B involvement in POAG pathogenesis. Cells 9(9), 1934 (2020).","journal-title":"Cells"},{"key":"13573_CR45","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/S0065-230X(08)60099-8","volume":"71","author":"MJ Ravitz","year":"1997","unstructured":"Ravitz, M. J. & Wenner, C. E. Cyclin-dependent kinase regulation during G l phase and cell cycle regulation by TGF-\u03b2. Adv. Cancer Res. 71, 165\u2013207 (1997).","journal-title":"Adv. Cancer Res."},{"issue":"1","key":"13573_CR46","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1167\/iovs.05-1060","volume":"47","author":"DL Fleenor","year":"2005","unstructured":"Fleenor, D. L. et al. TGFbeta2-induced changes in human trabecular meshwork: Implications for intraocular pressure. Invest. Ophthalmol. Vis. Sci. 47(1), 226\u2013234 (2005).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"6","key":"13573_CR47","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1016\/S0161-6420(84)34248-8","volume":"91","author":"J Alvarado","year":"1984","unstructured":"Alvarado, J., Murphy, C. & Juster, R. Trabecular meshwork cellularity in primary open-angle glaucoma and nonglaucomatous normals. Ophthalmology 91(6), 564\u2013579 (1984).","journal-title":"Ophthalmology"},{"issue":"2","key":"13573_CR48","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1038\/eye.1987.38","volume":"1","author":"I Grierson","year":"1987","unstructured":"Grierson, I. & Howes, R. C. Age-related depletion of the cell population in the human trabecular meshwork. Eye 1(2), 204\u2013210 (1987).","journal-title":"Eye"},{"issue":"11","key":"13573_CR49","doi-asserted-by":"publisher","first-page":"8287","DOI":"10.1167\/iovs.11-8218","volume":"52","author":"KE Bollinger","year":"2011","unstructured":"Bollinger, K. E. et al. Quantitative proteomics: TGF\u03b22 signaling in trabecular meshwork cells. Invest. Ophthalmol. Vis. Sci. 52(11), 8287\u20138294 (2011).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"11","key":"13573_CR50","doi-asserted-by":"publisher","first-page":"5718","DOI":"10.1167\/iovs.10-5679","volume":"51","author":"AL Yu","year":"2010","unstructured":"Yu, A. L., Birke, K., Moriniere, J. & Welge-L\u00fcssen, U. TGF-\u03b22 induces senescence-associated changes in human trabecular meshwork cells. Invest. Ophthalmol. Vis. Sci. 51(11), 5718\u20135723 (2010).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"1","key":"13573_CR51","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1677\/JOE-08-0549","volume":"202","author":"Y Xia","year":"2009","unstructured":"Xia, Y. & Schneyer, A. L. The biology of activin: Recent advances in structure, regulation and function. J. Endocrinol. 202(1), 1\u201312 (2009).","journal-title":"J. Endocrinol."},{"issue":"2","key":"13573_CR52","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1167\/iovs.06-0226","volume":"48","author":"R Fuchshofer","year":"2007","unstructured":"Fuchshofer, R., Yu, A. H. L., Welge-L\u00fcssen, U. & Tamm, E. R. Bone morphogenetic protein-7 is an antagonist of transforming growth factor-\u03b22 in human trabecular meshwork cells. Invest. Ophthalmol. Vis. Sci. 48(2), 715\u2013726 (2007).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"6","key":"13573_CR53","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1007\/s12265-012-9400-9","volume":"5","author":"KD Panse","year":"2012","unstructured":"Panse, K. D. et al. Follistatin-like 3 mediates paracrine fibroblast activation by cardiomyocytes. J. Cardiovasc. Transl. Res. 5(6), 814\u2013826 (2012).","journal-title":"J. Cardiovasc. Transl. Res."},{"issue":"1","key":"13573_CR54","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ajur.2015.11.002","volume":"3","author":"AM Blee","year":"2016","unstructured":"Blee, A. M. & Huang, H. PMEPA1 guards against TGF-\u03b2-mediated prostate cancer bone metastasis. Asian J. Urol. 3(1), 1\u20133 (2016).","journal-title":"Asian J. Urol."},{"key":"13573_CR55","first-page":"1881","volume":"18","author":"Y Su","year":"2012","unstructured":"Su, Y. et al. Smad7 siRNA inhibit expression of extracellular matrix in trabecular meshwork cells treated with TGF-\u03b22. Mol. Vis. 18, 1881\u20131884 (2012).","journal-title":"Mol. Vis."},{"issue":"24","key":"13573_CR56","doi-asserted-by":"publisher","first-page":"21397","DOI":"10.1074\/jbc.M010783200","volume":"276","author":"L Ulloa","year":"2001","unstructured":"Ulloa, L. & Tabibzadeh, S. Lefty inhibits receptor-regulated smad phosphorylation induced by the activated transforming growth factor-\u03b2 receptor. J. Biol. Chem. 276(24), 21397\u201321404 (2001).","journal-title":"J. Biol. Chem."},{"key":"13573_CR57","first-page":"1881","volume":"18","author":"Y Su","year":"2012","unstructured":"Su, Y. et al. Smad7 siRNA inhibit expression of extracellular matrix in trabecular meshwork cells. Mol. Vis. 18, 1881 (2012).","journal-title":"Mol. Vis."},{"issue":"1","key":"13573_CR58","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1074\/jbc.M108103200","volume":"277","author":"JM Mason","year":"2002","unstructured":"Mason, J. M. et al. Lefty contributes to the remodeling of extracellular matrix by inhibition of connective tissue growth factor and collagen mRNA expression and increased proteolytic activity in a fibrosarcoma model. J. Biol. Chem. 277(1), 407\u2013415 (2002).","journal-title":"J. Biol. Chem."},{"issue":"6","key":"13573_CR59","doi-asserted-by":"publisher","first-page":"2386","DOI":"10.1016\/j.ajpath.2012.02.030","volume":"180","author":"B Junglas","year":"2012","unstructured":"Junglas, B. et al. \u2018Connective tissue growth factor causes glaucoma by modifying the actin cytoskeleton of the trabecular meshwork\u2019. Am. J. Pathol. 180(6), 2386\u20132403 (2012).","journal-title":"Am. J. Pathol."},{"key":"13573_CR60","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.matbio.2014.03.007","volume":"37","author":"DM Wallace","year":"2014","unstructured":"Wallace, D. M., Murphy-Ullrich, J. E., Downs, J. C. & O\u2019Brien, C. J. The role of matricellular proteins in glaucoma. Matrix Biol. 37, 174\u2013182 (2014).","journal-title":"Matrix Biol."},{"issue":"4","key":"13573_CR61","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1111\/j.1476-5381.2010.01103.x","volume":"162","author":"R Rosenthal","year":"2011","unstructured":"Rosenthal, R. & Fromm, M. Endothelin antagonism as an active principle for glaucoma therapy. Br. J. Pharmacol. 162(4), 806\u2013816 (2011).","journal-title":"Br. J. Pharmacol."},{"issue":"3","key":"13573_CR62","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1097\/00061198-200206000-00016","volume":"11","author":"T Yorio","year":"2002","unstructured":"Yorio, T., Krishnamoorthy, R. & Prasanna, G. Endothelin: Is it a contributor to glaucoma pathophysiology?. J. Glaucoma. 11(3), 259\u2013270 (2002).","journal-title":"J. Glaucoma."},{"issue":"7","key":"13573_CR63","doi-asserted-by":"publisher","first-page":"2991","DOI":"10.1167\/iovs.16-20974","volume":"58","author":"EH Zhou","year":"2017","unstructured":"Zhou, E. H. et al. A compact whole-eye perfusion system to evaluate pharmacologic responses of outflow facility. Invest. Ophthalmol. Vis. Sci. 58(7), 2991\u20133003 (2017).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"1","key":"13573_CR64","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1159\/000083021","volume":"37","author":"M Cellini","year":"2005","unstructured":"Cellini, M., Versura, P., Trer\u00e8, D. & Campos, E. C. Effects of endothelin-1 on human trabecular meshwork cell contraction: An in vitro cell culture model. Ophthalmic Res. 37(1), 43\u201349 (2005).","journal-title":"Ophthalmic Res."},{"issue":"8","key":"13573_CR65","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1007\/s00417-008-0817-4","volume":"246","author":"G Renieri","year":"2008","unstructured":"Renieri, G. et al. Effects of endothelin-1 on calcium-independent contraction of bovine trabecular meshwork. Graefe\u2019s Arch. Clin. Exp. Ophthalmol. 246(8), 1107\u20131115 (2008).","journal-title":"Graefe\u2019s Arch. Clin. Exp. Ophthalmol."},{"issue":"6","key":"13573_CR66","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1016\/j.exer.2004.12.013","volume":"80","author":"R Rosenthal","year":"2005","unstructured":"Rosenthal, R. et al. Effects of ML-7 and Y-27632 on carbachol- and endothelin-1-induced contraction of bovine trabecular meshwork. Exp. Eye Res. 80(6), 837\u2013845 (2005).","journal-title":"Exp. Eye Res."},{"issue":"2","key":"13573_CR67","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/S0014-4835(05)80042-9","volume":"61","author":"M Wiederholt","year":"1995","unstructured":"Wiederholt, M., Bielka, S., Schweig, F., L\u00fctjen-Drecoll, E. & Lepple-Wienhues, A. Regulation of outflow rate and resistance in the perfused anterior segment of the bovine eye. Exp. Eye Res. 61(2), 223\u2013234 (1995).","journal-title":"Exp. Eye Res."},{"issue":"4","key":"13573_CR68","doi-asserted-by":"publisher","first-page":"1608","DOI":"10.1172\/JCI71195","volume":"124","author":"I Daehn","year":"2014","unstructured":"Daehn, I. et al. Endothelial mitochondrial oxidative stress determines podocyte depletion in segmental glomerulosclerosis. J. Clin. Investig. 124(4), 1608\u20131621 (2014).","journal-title":"J. Clin. Investig."},{"issue":"1","key":"13573_CR69","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/antiox10010107","volume":"10","author":"HY Chen","year":"2021","unstructured":"Chen, H. Y. et al. Characterization of tgf-\u03b2 by induced oxidative stress in human trabecular meshwork cells. Antioxidants 10(1), 1\u201331 (2021).","journal-title":"Antioxidants"},{"key":"13573_CR70","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.redox.2014.01.012","volume":"2","author":"F Jiang","year":"2014","unstructured":"Jiang, F., Liu, G.-S., Dusting, G. J. & Chan, E. C. NADPH oxidase-dependent redox signaling in TGF-\u03b2-mediated fibrotic responses. Redox Biol. 2, 267\u2013272 (2014).","journal-title":"Redox Biol."},{"issue":"4","key":"13573_CR71","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1167\/iovs.62.4.4","volume":"62","author":"VR Rao","year":"2021","unstructured":"Rao, V. R. & Stubbs, E. B. TGF-\u03b22 promotes oxidative stress in human trabecular meshwork cells by selectively enhancing NADPH oxidase 4 expression. Investig. Opthalmol. Vis. Sci. 62(4), 4 (2021).","journal-title":"Investig. Opthalmol. Vis. Sci."},{"key":"13573_CR72","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.exer.2016.08.023","volume":"158","author":"PV Rao","year":"2017","unstructured":"Rao, P. V., Pattabiraman, P. P. & Kopczynski, C. Role of the Rho GTPase\/Rho kinase signaling pathway in pathogenesis and treatment of glaucoma: Bench to bedside research. Exp. Eye Res. 158, 23\u201332 (2017).","journal-title":"Exp. Eye Res."},{"key":"13573_CR73","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.3892\/ijo.2013.2100","volume":"43","author":"J Wang","year":"2013","unstructured":"Wang, J., Liu, X. & Zhong, Y. Rho\/Rho-associated kinase pathway in glaucoma. Int. J. Oncol. 43, 1357\u20131367 (2013).","journal-title":"Int. J. Oncol."},{"key":"13573_CR74","doi-asserted-by":"publisher","first-page":"15286","DOI":"10.1038\/s41598-021-94791-4","volume":"11","author":"M Watanabe","year":"2021","unstructured":"Watanabe, M. et al. Diverse effects of pan-ROCK and ROCK2 inhibitors on 2 D and 3D cultured human trabecular meshwork (HTM) cells treated with TGF\u03b22. Sci. Rep. 11, 15286 (2021).","journal-title":"Sci. Rep."},{"issue":"2","key":"13573_CR75","first-page":"110","volume":"1","author":"AA Ghanem","year":"2021","unstructured":"Ghanem, A. A., Mokbel, T., Ghanem, A. A. & Elnokrashy, A. Rho-kinase inhibitors as a novel medication for glaucoma treatment: A review of the literature. Egypt. J. Ophthalmol. 1(2), 110\u201320 (2021).","journal-title":"Egypt. J. Ophthalmol."},{"key":"13573_CR76","doi-asserted-by":"publisher","first-page":"2211","DOI":"10.1007\/s40265-014-0333-2","volume":"74","author":"KP Garnock-Jones","year":"2014","unstructured":"Garnock-Jones, K. P. Ripasudil: First global approval. Drugs 74, 2211\u20132215 (2014).","journal-title":"Drugs"},{"key":"13573_CR77","doi-asserted-by":"publisher","first-page":"e26","DOI":"10.1111\/aos.12829","volume":"94","author":"H Tanihara","year":"2016","unstructured":"Tanihara, H. et al. One-year clinical evaluation of 0.4% ripasudil (K-115) in patients with open-angle glaucoma and ocular hypertension. Acta Ophthalmol. 94, e26\u2013e34 (2016).","journal-title":"Acta Ophthalmol."},{"key":"13573_CR78","doi-asserted-by":"publisher","first-page":"2475","DOI":"10.1016\/j.bmcl.2016.03.104","volume":"26","author":"JM Sturdivant","year":"2016","unstructured":"Sturdivant, J. M. et al. Discovery of the ROCK inhibitor netarsudil for the treatment of open-angle glaucoma. Bioorg. Med. Chem. Lett. 26, 2475\u20132480 (2016).","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"13573_CR79","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.exer.2016.07.012","volume":"158","author":"CL Pervan","year":"2017","unstructured":"Pervan, C. L. Smad-independent TGF-\u03b22 signaling pathways in human trabecular meshwork cells. Exp. Eye Res. 158, 137\u2013145 (2017).","journal-title":"Exp. Eye Res."},{"issue":"3","key":"13573_CR80","first-page":"1201","volume":"41","author":"X Wang","year":"2018","unstructured":"Wang, X. et al. Mutual regulation of the Hippo\/Wnt\/LPA\/TGF-\u03b2 signaling pathways and their roles in glaucoma (Review). Int. J. Mol. Med. 41(3), 1201\u20131212 (2018).","journal-title":"Int. J. Mol. Med."},{"issue":"1","key":"13573_CR81","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1111\/jcmm.14792","volume":"24","author":"J Yan","year":"2020","unstructured":"Yan, J. et al. Integrative transcriptomic and proteomic analysis reveals CD9\/ITGA4\/PI3K-Akt axis mediates trabecular meshwork cell apoptosis in human glaucoma. J. Cell. Mol. Med. 24(1), 814\u2013829 (2020).","journal-title":"J. Cell. Mol. Med."},{"key":"13573_CR82","first-page":"26 e921514","volume":"17","author":"M Wang","year":"2020","unstructured":"Wang, M., Li, J. & Zheng, Y. The potential role of nuclear factor erythroid 2-related factor 2 (Nrf2) in glaucoma: A review. Med. Sci. Monit. 17, 26 e921514 (2020).","journal-title":"Med. Sci. Monit."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-13573-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-13573-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-13573-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T16:03:11Z","timestamp":1763568191000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-13573-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,10]]},"references-count":82,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["13573"],"URL":"https:\/\/doi.org\/10.1038\/s41598-022-13573-8","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,10]]},"assertion":[{"value":"4 October 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 June 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"9564"}}